-
Something wrong with this record ?
LC-UV/MS methods for the analysis of prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone (BSIH) and its active chelator salicylaldehyde isonicotinoyl hydrazone (SIH)
J. Bureš, H. Jansová, J. Stariat, T. Filipský, P. Mladěnka, T. Šimůnek, R. Kučera, J. Klimeš, Q. Wang, KJ. Franz, P. Kovaříková,
Language English Country England, Great Britain
Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- MeSH
- Aldehydes analysis blood MeSH
- Chelating Agents analysis MeSH
- Chromatography, Liquid methods MeSH
- Mass Spectrometry methods MeSH
- Hydrazones analysis blood MeSH
- Culture Media chemistry MeSH
- Boronic Acids analysis blood MeSH
- Isonicotinic Acids analysis blood MeSH
- Molecular Structure MeSH
- Rats, Wistar MeSH
- Reference Standards MeSH
- Sensitivity and Specificity MeSH
- Spectrophotometry, Ultraviolet methods MeSH
- Drug Stability MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Extramural MeSH
Salicylaldehyde isonicotinoyl hydrazone (SIH) is an intracellular iron chelator with well documented potential to protect against oxidative injury both in vitro and in vivo. However, it suffers from short biological half-life caused by fast hydrolysis of the hydrazone bond. Recently, a concept of boronate prochelators has been introduced as a strategy that might overcome these limitations. This study presents two complementary analytical methods for detecting the prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone-BSIH along with its active metal-binding chelator SIH in different solution matrices and concentration ranges. An LC-UV method for determination of BSIH and SIH in buffer and cell culture medium was validated over concentrations of 7-115 and 4-115 μM, respectively, and applied to BSIH activation experiments in vitro. An LC-MS assay was validated for quantification of BSIH and SIH in plasma over the concentration range of 0.06-23 and 0.24-23 μM, respectively, and applied to stability studies in plasma in vitro as well as analysis of plasma taken after i.v. administration of BSIH to rats. A Zorbax-RP bonus column and mobile phases containing either phosphate buffer with EDTA or ammonium formate and methanol/acetonitrile mixture provided suitable conditions for the LC-UV and LC-MS analysis, respectively. Samples were diluted or precipitated with methanol prior to analysis. These separative analytical techniques establish the first validated protocols to investigate BSIH activation by hydrogen peroxide in multiple matrices, directly compare the stabilities of the prochelator and its chelator in plasma, and provide the first basic pharmacokinetic data of this prochelator. Experiments reveal that BSIH is stable in all media tested and is partially converted to SIH by H2O2. The observed integrity of BSIH in plasma samples from the in vivo study suggests that the concept of prochelation might be a promising strategy for further development of aroylhydrazone cytoprotective agents.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16000437
- 003
- CZ-PrNML
- 005
- 20160126103548.0
- 007
- ta
- 008
- 160108s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jpba.2014.11.044 $2 doi
- 035 __
- $a (PubMed)25527982
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Bureš, Jan $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
- 245 10
- $a LC-UV/MS methods for the analysis of prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone (BSIH) and its active chelator salicylaldehyde isonicotinoyl hydrazone (SIH) / $c J. Bureš, H. Jansová, J. Stariat, T. Filipský, P. Mladěnka, T. Šimůnek, R. Kučera, J. Klimeš, Q. Wang, KJ. Franz, P. Kovaříková,
- 520 9_
- $a Salicylaldehyde isonicotinoyl hydrazone (SIH) is an intracellular iron chelator with well documented potential to protect against oxidative injury both in vitro and in vivo. However, it suffers from short biological half-life caused by fast hydrolysis of the hydrazone bond. Recently, a concept of boronate prochelators has been introduced as a strategy that might overcome these limitations. This study presents two complementary analytical methods for detecting the prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone-BSIH along with its active metal-binding chelator SIH in different solution matrices and concentration ranges. An LC-UV method for determination of BSIH and SIH in buffer and cell culture medium was validated over concentrations of 7-115 and 4-115 μM, respectively, and applied to BSIH activation experiments in vitro. An LC-MS assay was validated for quantification of BSIH and SIH in plasma over the concentration range of 0.06-23 and 0.24-23 μM, respectively, and applied to stability studies in plasma in vitro as well as analysis of plasma taken after i.v. administration of BSIH to rats. A Zorbax-RP bonus column and mobile phases containing either phosphate buffer with EDTA or ammonium formate and methanol/acetonitrile mixture provided suitable conditions for the LC-UV and LC-MS analysis, respectively. Samples were diluted or precipitated with methanol prior to analysis. These separative analytical techniques establish the first validated protocols to investigate BSIH activation by hydrogen peroxide in multiple matrices, directly compare the stabilities of the prochelator and its chelator in plasma, and provide the first basic pharmacokinetic data of this prochelator. Experiments reveal that BSIH is stable in all media tested and is partially converted to SIH by H2O2. The observed integrity of BSIH in plasma samples from the in vivo study suggests that the concept of prochelation might be a promising strategy for further development of aroylhydrazone cytoprotective agents.
- 650 _2
- $a aldehydy $x analýza $x krev $7 D000447
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kyseliny boronové $x analýza $x krev $7 D001897
- 650 _2
- $a chelátory $x analýza $7 D002614
- 650 _2
- $a chromatografie kapalinová $x metody $7 D002853
- 650 _2
- $a kultivační média $x chemie $7 D003470
- 650 _2
- $a stabilita léku $7 D004355
- 650 _2
- $a hydrazony $x analýza $x krev $7 D006835
- 650 _2
- $a kyseliny isonikotinové $x analýza $x krev $7 D007539
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a hmotnostní spektrometrie $x metody $7 D013058
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a referenční standardy $7 D012015
- 650 _2
- $a senzitivita a specificita $7 D012680
- 650 _2
- $a spektrofotometrie ultrafialová $x metody $7 D013056
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Jansová, Hana $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
- 700 1_
- $a Stariat, Ján $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
- 700 1_
- $a Filipský, Tomáš $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
- 700 1_
- $a Mladěnka, Přemysl $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
- 700 1_
- $a Šimůnek, Tomáš $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
- 700 1_
- $a Kučera, Radim $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
- 700 1_
- $a Klimeš, Jiří $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
- 700 1_
- $a Wang, Qin $u Duke University, Department of Chemistry, Durham, NC 22708, USA.
- 700 1_
- $a Franz, Katherine J $u Duke University, Department of Chemistry, Durham, NC 22708, USA.
- 700 1_
- $a Kovaříková, Petra $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. Electronic address: petra.kovarikova@faf.cuni.cz.
- 773 0_
- $w MED00002894 $t Journal of pharmaceutical and biomedical analysis $x 1873-264X $g Roč. 105, č. - (2015), s. 55-63
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25527982 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160108 $b ABA008
- 991 __
- $a 20160126103711 $b ABA008
- 999 __
- $a ok $b bmc $g 1102718 $s 924643
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 105 $c - $d 55-63 $e 20141203 $i 1873-264X $m Journal of pharmaceutical and biomedical analysis $n J Pharm Biomed Anal $x MED00002894
- LZP __
- $a Pubmed-20160108